Jun 7, 2023 | Press Releases
Cambridge, MA, June 7, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced that Dr. K. Arnold Chan joined the company as Senior Vice President, Real-World Evidence...
Jun 1, 2023 | Press Releases
Cambridge, MA, June 1, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, enabled researchers at Hospital Quirónsalud Marbella and Hospital Campo de Gibraltar to leverage European...
May 22, 2023 | Press Releases
Nancy, France, May 22, 2023 — The Centre Hospitalier Régional Universitaire (CHRU) de Nancy, one of the leading research institutions in France, announced it is partnering with TriNetX to attain access to global real-world data (RWD) to generate real-world evidence...
Apr 12, 2023 | Press Releases
TherapyMonitor Reports Offer Regulatory-Grade Insights Built Upon European Longitudinal and Representative Patient-Level Real-World Data Cambridge, MA, April 12, 2023 — TriNetX, through its wholly owned subsidiary TriNetX Oncology GmbH, announces the availability of...
Apr 4, 2023 | Press Releases
As part of the strategic partnership between Norstella and TriNetX, TriNetX will acquire Norstella’s Clinerion subsidiary. Cambridge, MA, April 4, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development...
Feb 21, 2023 | Press Releases
Cambridge, MA, February 21, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced a strategic collaboration with Chrysalis Advisory, also known as Chrysalis Health...
Feb 14, 2023 | Press Releases
Cambridge, MA, February 14, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced that Arnaub Chatterjee has joined the company as Chief Product and Solutions Officer....
Jan 17, 2023 | Press Releases
Cambridge, MA, January 17, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced that Shields Carstarphen has joined the company as Chief Commercial Officer. “We are...
Jan 6, 2023 | Blog, Events, Published Research
In December, a contingent of our real-world data experts attended the 2022 Annual Meeting of the American Society of Hematology. Led by Chief Scientific Officer Jeffrey Brown and Senior Vice President, TriNetX Oncology GmbH Lenka Kellerman, our team spent their time...
